ITolerance, Inc. | Finanzwire

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
ITolerance, Inc.

BRIEF

published on 06/24/2024 at 19:05, 5 months 27 days ago

University of Miami Announces Breakthrough in Diabetes Treatment at ADA 2024

Innovation Diabetes Transplantation Stem Cells ITolerance
PRESS RELEASE

published on 06/24/2024 at 19:00, 5 months 27 days ago

The Diabetes Research Institute, University of Miami, Announces Breakthrough Transplantation Approach for the Treatment of Type 1 Diabetes at ADA 2024
iTolerance Inc. announces breakthrough results with innovative approach combining human stem cell-derived islets and immunomodulatory microgel to reverse Type 1 Diabetes, presented at ADA's 84th Scientific Sessions

ITolerance Inc. Type 1 Diabetes Human Stem Cell-derived Islets Immunomodulatory Microgel Diabetes Reversal
PRESS RELEASE

published on 01/04/2024 at 17:00, 11 months 17 days ago

iTolerance, Inc. to Present at Biotech Showcase(TM) 2024
iTolerance, Inc. has announced that Dr. Anthony Japour, Chief Executive Officer, will present at Biotech Showcase™ 2024 on January 8, 2024, at 11:30 AM PT in San Francisco, CA. The event provides an opportunity for the company to connect with investors and pharmaceutical executives and features multiple tracks of presenting companies, plenary sessions, and networking. iTolerance is focused on developing regenerative medicines, with the potential to cure diseases. For more information about the event, please visit the conference website.

Biotech Showcase 2024 ITolerance Inc. Regenerative Medicines Investor Conference Biotechnology
PRESS RELEASE

published on 11/07/2023 at 15:00, 1 year 1 month ago

iTolerance, Inc. and Kadimastem Ltd. Submit Initial Targeted Engagement for Regulatory Advice on CBER Products (INTERACT) Meeting Request with FDA for Potential Cure for Type 1 Diabetes
PRESS RELEASE

published on 10/11/2023 at 16:00, 1 year 2 months ago

iTolerance, Inc. to Participate at the Virtual Investor Ask the CEO Conference

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 48 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 48 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 13 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 18 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 48 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 26 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 33 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE